4.5 Article

Construction of an Escherichia coli cell factory to synthesize taxadien-5α-ol, the key precursor of anti-cancer drug paclitaxel

Journal

BIORESOURCES AND BIOPROCESSING
Volume 9, Issue 1, Pages -

Publisher

SPRINGER HEIDELBERG
DOI: 10.1186/s40643-022-00569-5

Keywords

Oxygenated taxanes; Metabolic engineering; Taxadiene-5 alpha-hydroxylase; Fusion protein; Mevalonate pathway; Paclitaxel; Escherichia coli

Funding

  1. National Key Research and Development Program of China [2019YFA0905000]
  2. National Natural Science Foundation of China [21922804, 21871085]
  3. Program of Shanghai Academic Research Leader [21XD1400800]
  4. Fundamental Research Funds for the Central Universities [22221818014]

Ask authors/readers for more resources

This study reports the construction of a microbial cell factory in Escherichia coli for the biosynthesis of the anticancer drug paclitaxel. By screening key enzymes and optimizing fermentation conditions, the production of taxadien-5 alpha-ol, the precursor of paclitaxel, was significantly improved. The engineered pathway can potentially be used for the production of other valuable terpenoids.
Paclitaxel (Taxol (TM)), an alkaloid of diterpenoid family, is one of the most widely used anti-cancer drugs due to its effectiveness against a variety of tumors. Rather than directly extraction and chemical synthesis of paclitaxel or its intermediates from yew plants, construction of a microbial cell factory for paclitaxel biosynthesis will be more efficient and sustainable. The challenge for biosynthesis of paclitaxel lies on the insufficient precursor, such as taxadien-5 alpha-ol. In this study, we report a recombinant Escherichia coli strain constructed with a heterologous mevalonate pathway, a taxadiene synthase from yew, and a cytochrome P450-mediated oxygenation system for the de novo production of taxadien-5 alpha-ol, the first product of the multi-step taxadiene oxygenation metabolism. The key enzymes including taxadiene synthases and cytochrome P450 reductases were screened, and the linker for fusing taxadiene-5 alpha-hydroxylase with its reductase partner cytochrome P450 reductase was optimized. By reducing the metabolic burden and optimizing the fermentation conditions, the final production of total oxygenated taxanes was raised up to 27 mg L(-1 )in a 50-mL flask cultivation, of which the yield of taxadien-5 alpha-ol was 7.0 mg L-1, representing approximately a 12-fold and 23-fold improvements, respectively, as compared with the initial titers. The engineered MVA pathway for the overproduction of terpenoid precursors can serve as an efficient platform for the production of other valuable terpenoids.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available